Phreesia, Inc.
Phreesia, Inc. (PHR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
phr · pe ratio · data through Jan 31, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Phreesia, Inc. (PHR) measures how much investors pay for each dollar of the company's trailing earnings. PHR's current PE ratio of 61.99x is calculated by dividing its stock price of $9.34 by its TTM earnings per share of $0.15. −82.2% discount vs 5Y avg 347.9x
Source: FMP · /ratios-ttm · /analyst-estimates · 2026-01-31
PE Ratio History
2018 – 2026 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Phreesia, Inc.You PHR | $577M | 61.99x | — | $0.15 |
 BioLife Solutions, Inc. BLFS | $1.3B | N/A | — | -$0.25 |
 Establishment Labs Holdings Inc. ESTA | $2.2B | N/A | — | -$1.72 |
 GoodRx Holdings, Inc. GDRX | $912M | 31.72x | — | $0.09 |
 Kestra Medical Technologies, Ltd. KMTS | $1.2B | N/A | — | -$2.30 |
 Neogen Corporation NEOG | $2.0B | N/A | — | -$5.03 |
 NovoCure Limited NVCR | $2.0B | N/A | — | -$1.22 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2026-01-31Latest FY2026 | 347.91x | $0.04 | — | |
2025-01-31 FY2025 | — | $-1.02 | — | |
2024-01-31 FY2024 | — | $-2.51 | — | |
2023-01-31 FY2023 | — | $-3.36 | — | |
2022-01-31 FY2022 | — | $-2.37 | — | |
2021-01-31 FY2021 | — | $-0.69 | — | |
2020-01-31 FY2020 | — | $-1.00 | — | |
2019-01-31 FY2019 | — | $-8.16 | — | |
2018-01-31 FY2018 | — | $-11.82 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Phreesia, Inc. (PHR) measures how much investors pay for each dollar of the company's trailing earnings. PHR's current PE ratio of 61.99x is calculated by dividing its stock price of $9.34 by its TTM earnings per share of $0.15.
Frequently asked questions
PHR pe ratio · 6 questionsPHR's current PE ratio is 61.99x as of 2026-06-08, based on a stock price of $9.34 and TTM EPS of $0.15. Data sourced from Financial Modeling Prep via PHR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Phreesia, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08